Household & Personal Products

Clorox’s Q2 2026 webcast, new allergen‑neutraliser launch and ERP upgrade show the company’s focus on health‑conscious products, operational efficiency and dividend‑growth, even as analysts tighten price targets. Discover how these moves shape its n…

Clorox launches allergen‑neutralizing PURE™ sprays to tap growing indoor‑wellness trend, while a cloud‑based ERP upgrade targets cost cuts and margin recovery.

Colgate‑Palmolive’s $81.93 stock balances strong margins, pet‑nutrition growth and ESG focus—yet faces digital, supply‑chain and regulatory risks that could shape its future.

Procter & Gamble’s steady revenue growth masks hidden risks—from EU reformulation costs to private‑label pressure—yet new health‑tech and DTC channels could unlock hidden growth.

Unilever faces a BNP Paribas downgrade amid a $5 trillion+ daily‑goods boom—can its sustainability plan offset margin pressure and regulatory risks?

Clorox’s dividend allure clashes with earnings uncertainty as its ERP overhaul seeks to boost efficiency amid sector pressure.

Procter & Gamble’s shares stay steady, mirroring consumer‑staples resilience amid low volatility and solid valuation—ideal for investors seeking stable, defensive growth.

Colgate‑Palmolive’s brokerage upgrade highlights its resilient cash flow, growing pet‑nutrition line, ESG leadership, and steady dividend, signaling solid growth prospects.

Procter & Gamble’s share dip amid geopolitical tension is offset by a swift Texas packaging tweak that keeps Crest toothpaste on shelves and investors reassured.

Kimberly‑Clark’s dividend yield stays above the S&P 500 average as it leverages strong cash flow, brand moat and potential M&A to sustain income and growth.